Gene · 6241
Papers4,414
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,414
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deciphering the let-7c-5p/RRM2 axis in lung adenocarcinoma: expression, prognosis, and immune landscape implications. | Front Oncol | 2025 | 41357570 | PubTator, text mining | PubMed |
| Developing a prognostic stratification model based on glutathione metabolism in thyroid cancer and validating RRM2's tumor-promoting role. | Front Oncol | 2025 | 41333212 | PubTator, text mining | PubMed |
| Clinical application and drug resistance mechanism of gemcitabine. | Front Cell Dev Biol | 2025 | 41293424 | PubTator, text mining | PubMed |
| Potential Biomarkers and Therapeutic Targets of Non-Small Cell Lung Cancer. | Altern Ther Health Med | 2025 | 41289369 | PubTator, text mining | PubMed |
| CDC6 promotes the development and progression of clear cell renal cell carcinoma via upregulating RRM2. | Hum Cell | 2025 | 41283970 | PubTator, text mining | PubMed |
| RRM2 attenuates the renal tubular ferroptosis in diabetic kidney disease through PI3K/Akt/Nrf2 pathway. | World J Diabetes | 2025 | 41278435 | PubTator, text mining | PubMed |
| Impact of the Warburg effect on nucleotide homeostasis in human retinal endothelial cells and its relevance to proliferative diabetic retinopathy. | Front Pharmacol | 2025 | 41256261 | PubTator, text mining | PubMed |
| RRM2 contributes to pathogenic phenotype of fibroblast-like synoviocytes by activating NF-κB signaling and inhibiting ferroptosis in rheumatoid arthritis. | J Orthop Surg Res | 2025 | 41204303 | PubTator, text mining | PubMed |
| Roles of nucleotide metabolism in pancreatic cancer. | Front Immunol | 2025 | 41200180 | PubTator, text mining | PubMed |
| Identification of Prognostic Gene Signatures for Survival of Patients With Phaeochromocytoma, Paraganglioma, and Other Tumor Types. | Cancer Diagn Progn | 2025 | 41179328 | PubTator, text mining | PubMed |
| Evodiamine Enhances Chemosensitivity in Colorectal Cancer by Targeting Ribonucleotide Reductase M2. | J Biochem Mol Toxicol | 2025 | 41121956 | PubTator, text mining | PubMed |
| Targeting RRM2 with dual-modal theranostic smart nanoresponder overcomes osimertinib resistance and triggers immune remodeling in NSCLC. | Sci Adv | 2025 | 41105786 | PubTator, text mining | PubMed |
| Ciclopirox suppresses poxvirus replication by targeting iron metabolism. | Antiviral Res | 2025 | 41067563 | PubTator, text mining | PubMed |
| In Silico Structural Modeling of the HuR-mRNA Complex: Insights into Structural and Functional Regulation. | J Chem Inf Model | 2025 | 41032726 | PubTator, text mining | PubMed |
| Machine learning reveals ferroptosis and therapeutic targets in rheumatoid arthritis. | Medicine (Baltimore) | 2025 | 41029156 | PubTator, text mining | PubMed |
| Detection of Genome-Wide IGF-1R Recruitment to Enhancer and Promoter Regions of Chromatin in Clinical Prostate Cancers. | Cancer Med | 2025 | 41028981 | PubTator, text mining | PubMed |
| Computational prediction of diagnostic biomarker candidates and prognostic gene signature from DNA replication-related genes in breast cancer. | Discov Oncol | 2025 | 41003934 | PubTator, text mining | PubMed |
| CYB5R4 sustains endothelial proliferation and ischemia-induced angiogenesis by maintaining RRM2-dependent nucleotide balance. | bioRxiv | 2025 | 41000936 | PubTator, text mining | PubMed |
| Proteomic profiling identifies miR-423-5p as a modulator of oncogenic metabolism in HCC. | J Transl Med | 2025 | 40993657 | PubTator, text mining | PubMed |
| MicroRNA-mediated regulation of autophagy in lung cancer: role in tumourigenesis and chemotherapy resistance. | Acad Oncol | 2025 | 40978098 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6241/papers?page=7